Mostrando 3 resultados de: 3
Filtros aplicados
Clinical Performance of Three Commercial SARS‐CoV‐2 Rapid Antigen Tests for Community-Dwelling Individuals in a Tropical Setting
ArticleAbstract: During the second year of the COVID-19 pandemic, the use of Rapid Diagnosis Antigen Tests (RDAgTs) fPalabras claves:antigen test, Certest, clinical performance, RapiGEN Ag test kit ®, SARS–CoV–2, SD-BiosensorAutores:Alexander Paolo Vallejo-Janeta, Bernardo Castro-Rodriguez, Carolina Viteri-Dávila, Diana Morales-Jadán, Ismar Alejandra Rivera-Olivero, Miguel Angel Garcia‑Bereguiain, Perez F.Fuentes:googlescopusAnalytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis.
ArticleAbstract: Background: Several RT-qPCR kits are available for SARS-CoV-2 diagnosis, some of them with EmergencyPalabras claves:Autores:Byron Freirepaspuel, Marilyn B. Cruz, Miguel Angel Garcia‑Bereguiain, Perez F., Vega-Marino P., Vélez A.Fuentes:googlescopusCorrigendum to “Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis” [Virology volume (2021) 154–156] (Virology (2021) 553 (154–156), (S004268222030218X), (10.1016/j.virol.2020.10.010))
OtherAbstract: 1. On the introduction section. The sentence “Also, it was recently authorized for SARS-CoV2 diagnosPalabras claves:Autores:Byron Freirepaspuel, Marilyn B. Cruz, Miguel Angel Garcia‑Bereguiain, Perez F., Vega-Marino P., Vélez A.Fuentes:googlescopus